SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000909012-01-000107
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
1
Group Members
FLEMING ROBERT INC / DAFLEMING US DISCOVERY FUND III, LPFLEMING US DISCOVERY OFFSHORE FUND III, LPFLEMING US DISCOVERY PARTNERS LPFLEMING US DISCOVERY, LLCROBERT FLEMING INC.

Document Format Files

Seq Description Document Type Size
1 IMPAX LABORATORIES 0001.txt SC 13D/A 55203
  Complete submission text file 0000909012-01-000107.txt   57655
Mailing Address 320 PARK AVE 11TH AND 12TH FL NEW YORK NY 10022
Business Address 320 PARK AVENUE 11TH & 12TH FL NEW YORK NY 10022 2125083600
FLEMING ROBERT INC / DA (Filed by) CIK: 0000902812 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0331
SIC: 0000

Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address 30831 HAYWARD AVE HAYWARD CA 94544 2152892220
IMPAX LABORATORIES INC (Subject) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48867 | Film No.: 1544895
SIC: 2834 Pharmaceutical Preparations